Friday, November 22, 2019
Print Current Session:
|
|
Friday
SESSION 72:
ADVANCES IN THE TREATMENT OF CAROTID STENOSIS: MESH COVERED STENTS FOR CAROTID ARTERY STENTING (CAS) AND UPDATE ON TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR) FOR CAS
|
|
SESSION 72 SCHEDULE | |
NEW DEVELOPMENTS IN MESH COVERED STENTS | |
8:05 AM - 7:59 AM | Update On The 3 Mesh Covered Stents For CAS: What Are The Differences Between Them And Overview Of What Is The Status Of Their Safety And Efficacy |
Presenter(s):Max Amor, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:06 AM - 8:11 AM | Update On The C-Guard Micronet Mesh Covered Stent For CAS: Longer Term Results: Advantages And Are There Late Downsides Like ISR Or Late Thrombosis |
Presenter(s):Piotr Musialek, MD, DPhil Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:12 AM - 8:17 AM | Value And Limitations Of Mesh Covered Stents For CAS In Symptomatic And Asymptomatic Patients: 6-Year Results: Are ISR And Thrombotic Occlusions A Problem: Technical Tips To Optimize Their Use |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:18 AM - 8:23 AM | Randomized Controlled Trial (RCT) Of CAS With C-Guard Mesh Covered Stent Versus Wallstent: Is There A Difference In Perioperative Strokes Or DW-MRI Brain Lesions Up To 12 Months: The IRON-GUARD Study |
Presenter(s):Laura Capoccia, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:24 AM - 8:29 AM | What Value Will Mesh Covered Stents Have In Improving CAS Outcomes: Is There A Downside |
Presenter(s):L. Nelson Hopkins, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:30 AM - 8:35 AM | Panel Discussion |
TCAR RELATED TOPICS | |
8:36 AM - 8:41 AM | ROADSTER 2 Trial Shows Low Stroke Risk With TCAR (Silk Road Medical) Even With Inexperienced Operators And In High Risk Patients With High Risk Lesions |
Presenter(s):Vikram S. Kashyap, MD / Christopher J. Kwolek, MD, MBA / Peter A. Schneider, MD / Richard P. Cambria, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:42 AM - 8:47 AM | TCAR Outcomes Compare Favorably With Those Of CEA Even In Symptomatic Medically High Risk Patients: A Propensity Matched Study Of 5160 Patients From The SVS VQI Registry |
Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:48 AM - 8:53 AM | DEBATE: TCAR Is Not Safer Than Transfemoral CAS: Based On Results From A Multicenter Registry |
Presenter(s):Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:54 AM - 8:59 AM | DEBATE: Not So: TCAR Is Safer Than Transfemoral CAS Especially In Older (> 77) High Risk Patients With High Risk Lesions: TCAR Should Be The Standard Of Care For Invasive Treatment |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:00 AM - 9:05 AM | DEBATE: Not So: In Experienced Hands And With Appropriate Precautions Transfemoral CAS Will Be The Best Invasive Treatment For Most Patients |
Presenter(s):Giancarlo Biamino, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:06 AM - 9:11 AM | Why TCAR Should Replace Transfemoral CAS And Why It Won’t |
Presenter(s):Venkatesh G. Ramaiah, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:12 AM - 9:17 AM | DEBATE: Why TCAR Should Replace CEA And Transfemoral CAS For Carotid Stenosis Patients Justifiably Requiring Invasive Treatment |
Presenter(s):Wesley S. Moore, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:18 AM - 9:23 AM | DEBATE: Not So: Why CEA Should Remain The Standard Of Care For Carotid Stenosis Patients Requiring Invasive Treatments |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:24 AM - 9:32 AM | Panel Discussion |
9:32 AM - 9:42 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 72 | |
previous | next |